Online citations, reference lists, and bibliographies.

Improving The Science And Politics Of Quality Improvement.

J. Randall Curtis, Mitchell M. Levy
Published 2011 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
QUALITY AND SAFETY ARE CRITICAL ISSUES FOR health care systems around the world and have appropriately been highlighted in ongoing efforts to reform and improve health care. Care of critically ill patients is a domain in which issues of quality and safety take on monumental importance because of the severity of illness and the complexity of providing highquality critical care. In this issue of JAMA, Scales and colleagues report the results of an important study designed to evaluate the effectiveness of quality improvement efforts in communitybased critical care units in Ontario. The authors use a multifaceted “knowledge transfer” intervention including education, dissemination of algorithms, and audit and feedback, transferred through an interactive telecommunication strategy. The goal of the intervention was to increase adherence to 6 quality measures that have been documented to improve patient outcomes: prevention of ventilator-associated pneumonia (VAP), prophylaxis for deep venous thrombosis (DVT), daily spontaneous breathing trials, prevention of catheter-related bloodstream infections, early enteral feeding, and prevention of decubitus ulcers. Although debate remains about some of the evidence supporting these measures, there is general consensus that appropriate implementation of each measure can decrease risk of harm for critically ill patients. Numerous studies have investigated the value and implementation of these quality measures, but the study by Scales and colleagues has several notable features. First, the design and implementation reflect state-of-the art methods for a study evaluating quality improvement and advancing the state of science. Second, the study design, knowledge transfer intervention, and analyses are extremely complex but appropriate to the complex phenomenon under study. Third, the results were positive, documenting significant improvement in quality, although benefits were modest. Fourth, this study—with its state-of-the-art, complex methods—was funded by the Ontario health care delivery system rather than a research funding agency, which has important policy implications for improving health care in North America and beyond. Each of these 4 points warrants further discussion. Many studies have been designed to improve health care quality, but relatively few are randomized trials. Although much can be learned from nonrandomized and nonexperimental studies, the authors’ use of a randomized design with an appropriate control group improves their ability to control for bias and greatly enhances the ability to draw causal inferences. An observational study with historical controls would be unable to exclude temporal change as an explanation for the findings. These authors also addressed the problems that result from having the control group receive no intervention by using the same knowledge transfer intervention targeting different quality measures in pairs. Each intensive care unit was randomly assigned to simultaneously be the experimental group receiving the knowledge transfer intervention for one quality measure (eg, VAP prevention) and the control group receiving no knowledge transfer intervention for the other measure of the pair (eg, DVT prophylaxis). Additional innovative methods included a “decay-monitoring period” demonstrating that the improvements persist and qualitative interviews with participants to explore mechanisms of action and facilitators of success. Another feature of this study is its complexity. Rather than using the standard scientific method of changing one variable and examining its effect, the authors designed a multifaceted knowledge transfer intervention. Yet this complexity is not only appropriate; it is essential. Years of research suggest that multifaceted interventions are needed to change clinician behavior and transfer knowledge of best practices into the complicated health care system. The cluster randomized design is appropriate for an intervention targeting the hospital, yet requires complex statistical approaches to account for clustering by center, can significantly reduce effective sample sizes (if intracluster correlations are high), and substantially reduces effectiveness of randomization, thereby increasing risk of randomization imbal-
This paper references
10.1136/bmj.317.7156.465
Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings
Lisa A. Bero (1998)
10.1200/JCO.2002.08.004
Oncologists' attitudes toward and practices in giving bad news: an exploratory study.
Walter F. Baile (2002)
10.1002/cncr.24206
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.
Nada A. Fadul (2009)
10.1164/rccm.200903-0450ST
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine.
Jeremy M Kahn (2010)
10.1200/jco.1998.16.5.1986
Cancer care during the last phase of life.
David S. Gordon (1998)
10.1001/jama.1994.03520230049037
The Impact of Serious Illness on Patients' Families
Kenneth E. Covinsky (1994)
10.1111/j.1440-1797.2010.01417.x
Renal palliative care in Australia: time to engage.
Mark A Brown (2011)
10.1001/jama.2010.2000
A multifaceted intervention for quality improvement in a network of intensive care units: a cluster randomized trial.
Damon C. Scales (2011)
10.1093/annonc/mdm121
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer.
Florence Joly (2007)
10.1200/JCO.2007.13.8156
Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
Christopher M Booth (2008)
10.6004/jnccn.2009.0012
Breast cancer. Clinical practice guidelines in oncology.
Robert W. Carlson (2009)
10.1186/1471-2407-9-130
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
Janette L Vardy (2008)
10.1056/NEJMoa062867
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
Brian J. Druker (2006)
10.1200/jco.2003.10.161
Setting goals to maintain hope.
Jamie Hayden Von Roenn (2003)
10.1200/JCO.2007.15.8253
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?
Craig C. Earle (2008)
Experts Debunk Health Care Reform Bill’s ‘Death Panel
K Snow (2009)
10.1056/nejm200103153441101
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Dennis J Slamon (2001)
10.1089/jpm.2009.0089
A comprehensive case management program to improve palliative care.
Claire M. Spettell (2009)
10.1056/NEJMp0900963
Medicare nonpayment, hospital falls, and unintended consequences.
Sharon K. Inouye (2009)
10.1016/S0140-6736(02)07810-8
Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial
Lesley Fallowfield (2002)
10.1001/archinte.168.16.1783
Cost savings associated with US hospital palliative care consultation programs.
Rolfe Sean Morrison (2008)
10.1007/s00520-007-0372-2
Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis
T. M. Robinson (2007)
10.1200/JCO.2001.19.6.1728
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Primo N. Lara (2001)
10.1093/jnci/djp177
How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question.
Tito Fojo (2009)
10.1378/chest.118.2_suppl.8S
Evidence for the effectiveness of techniques To change physician behavior.
Wally R. Smith (2000)
10.1097/01.QMH.0000267448.32629.f8
National Hospital Antibiotic Timing Measures for Pneumonia and Antibiotic Overuse
Douglas E. Drake (2007)
10.1200/JCO.2009.26.3863
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health.
Alexi A. Wright (2010)
10.1001/archinternmed.2007.84
Antibiotic timing and errors in diagnosing pneumonia.
James A. Welker (2008)
10.1016/S0885-3924(98)00149-3
The symptom burden of seriously ill hospitalized patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcome and Risks of Treatment.
Norman A. Desbiens (1999)
10.1056/NEJMoa011795
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
B Ertrand C Oiffier (2002)
10.1200/JCO.2003.09.124
Barriers to clinical trial participation by older women with breast cancer.
Margaret M. Kemeny (2003)
Health literacy, communication, and treatment decision-making in older cancer patients.
Sunil Amalraj (2009)
Experts Debunk Health Care Reform Bill ’ s ‘ Death Panel ’ Rule
K Snow
10.1001/archinternmed.2008.587
Health care costs in the last week of life: associations with end-of-life conversations.
B Zhang (2009)
10.6004/jnccn.2010.0056
Non-small cell lung cancer clinical practice guidelines in oncology.
David S. Ettinger (2006)
10.1200/JCO.2009.25.4672
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences.
Jennifer W Mack (2010)
10.1200/JCO.2008.20.2408
Faculty development to change the paradigm of communication skills teaching in oncology.
Anthony L. Back (2009)
CF: Setting goals to maintain hope
JH VonRoenn (2003)
10.1016/S1548-5315(11)70009-2
Providing palliative care and transitioning patients to hospice: how oncologists and palliative care specialists can work together
Sarah E. Harrington (2010)
10.1097/CCO.0b013e328352ea20
Early palliative care for patients with metastatic cancer
Jan Gaertner (2012)
10.1200/JCO.2008.19.9836
Metastatic renal cell carcinoma: many treatment options, one patient.
Brian I. Rini (2009)
10.3816/CLC.2008.n.015
Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599.
Robert A. Somer (2008)
10.1001/jama.282.9.867
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?
David A Davis (1999)
10.1002/ajh.21352
Update on the therapy for myelodysplastic syndrome.
Margaret T Kasner (2009)
Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer
Ma Dong (2006)
10.1056/NEJMp068132
Access before approval--a right to take experimental drugs?
Susan Okie (2006)
10.1200/JCO.2008.18.1420
Self-reported practices and attitudes of US oncologists regarding off-protocol therapy.
JEFFREYM. Peppercorn (2008)
10.1158/1078-0432.CCR-10-1278
Explaining Marginal Benefits to Patients, When “Marginal” Means Additional but Not Necessarily Small
Thomas J. Smith (2010)
10.1002/cncr.24761
Physician factors associated with discussions about end-of-life care.
Nancy L. Keating (2010)
10.6004/jnccn.2005.0024
Colon cancer. Clinical practice guidelines in oncology.
Paul F. Engstrom (2003)
10.1007/s00520-006-0027-8
Communication preferences and needs of cancer patients: the importance of content
Antonella Surbone (2006)
10.1016/S0140-6736(09)60221-X
Multiple myeloma
Marc S Raab (2009)
10.1016/j.jpainsymman.2006.10.010
Comparing hospice and nonhospice patient survival among patients who die within a three-year window.
Stephen Connor (2007)
10.1200/JCO.2007.12.4180
Oncologist communication about emotion during visits with patients with advanced cancer.
Kathryn I. Pollak (2007)
10.1097/01.COT.0000370073.55788.2A
Study: Few Physicians Discussing End-of-Life Options with Advanced-Stage Patients
James M. Stubenrauch (2010)
10.1200/JCO.2009.23.1183
American Society of Clinical Oncology guidance statement: the cost of cancer care.
Neal J. Meropol (2009)
10.1200/JCO.2008.20.1558
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology.
Frank D. Ferris (2009)
10.1097/01.CCM.0000114816.62331.08
Use of intensive care at the end of life in the United States: An epidemiologic study*
Derek C. Angus (2004)
10.1097/PPO.0b013e3181f28ab3
Palliative Chemotherapy: When Is It Worth It and When Is It Not?
Keith Mark Swetz (2010)
American Thoracic Society Pay-for- Performance Working Group. An official American Thoracic Society policy state- ment: pay-for-performance in pulmonary, critical care, and sleep medicine
JM Kahn (2010)



This paper is referenced by
10.1164/rccm.201107-1238ED
Partnering with health care payers to advance the science of quality improvement: lessons from the field.
Damon C. Scales (2011)
"How Do I Create A Quality Improvement Curriculum In My Training Program" Workshop References
Kohn Kt (2011)
10.1016/j.aorn.2011.11.001
Kaizen: a process improvement model for the business of health care and perioperative nursing professionals.
Hassan A Tetteh (2012)
10.1007/978-3-319-23748-0_3
Hospital Systems Management
Marianne Maumus (2015)
10.1111/pme.12075
Can assessing chronic pain outcomes data improve outcomes?
Lisa R. Witkin (2013)
Recommendations : Achieving the Potential of Health Care Performance Measures Timely Analysis of Immediate Health Policy Issues May 2013
Robert A. Berenson (2013)
Achieving the Potential of Health Care Performance Measures
Robert A. Berenson (2013)
10.1016/j.ccc.2012.10.008
Improving intensive care unit quality using collaborative networks.
Sam R. Watson (2013)
10.1200/JCO.2011.37.0437
Meta-analysis of psychosocial interventions to reduce pain in patients with cancer.
Sherri N Sheinfeld Gorin (2012)
10.1016/j.annemergmed.2014.06.007
Evaluation of an emergency department lean process improvement program to reduce length of stay.
Marian J. Vermeulen (2014)
10.1007/s11356-017-0807-3
Study on the influential biochemical indices of Cd(II) on Eisenia fetida in oxidative stress by principal component analysis in the natural soil
Yucui Ning (2017)
10.1097/CCM.0b013e3182982b03
Knowledge Translation Interventions for Critically Ill Patients: A Systematic Review*
Tasnim Sinuff (2013)
10.1097/QMH.0b013e31829a6a15
Seven Propositions of the Science of Improvement: Exploring Foundations
Rocco J. Perla (2013)
10.1097/PCC.0B013E31825E26B0
The SQUIRE has arrived
Richard J. Brilli (2012)
10.1001/jama.2016.0292
The Acute Respiratory Distress Syndrome: Dialing in the Evidence?
Brendan J Clark (2016)
10.1016/J.ZEFQ.2011.11.001
Entwicklung, Bewertung und Synthese von komplexen Interventionen – eine methodische Herausforderung
Ingrid Mühlhauser (2011)
Semantic Scholar Logo Some data provided by SemanticScholar